The role of 5HT1D-receptor agonists and magnesium in the treatment of migraine headache

被引：0
|
作者：
Alexander Mauskop
Jerome Goldstein
机构：
来源：
Current Pain and Headache Reports | 1997年 / 1卷 / 3期
关键词：
Migraine; Sumatriptan; Migraine Attack; Migraine Headache; Zolmitriptan;
D O I：
10.1007/BF02938172
中图分类号：
学科分类号：
摘要：
This article reviews two interesting topics in migraine treatment research. First, the effectiveness of sumatriptan is compared with that of the newer 5HT1D-agonists. Second, recent discoveries regarding the effect of magnesium on brain chemistry have yielcled evidence that this element may have a role in migraine. We offer our findings and opinion on this subject.
引用
收藏
页码：246 / 250
页数：4
相关论文
共 50 条
  • [1] 5-HT1F receptor agonists in acute migraine treatment:: a hypothesis
    Ramadan, NM
    Skljarevski, V
    Phebus, LA
    Johnson, KW
    CEPHALALGIA, 2003, 23 (08) : 776 - 785
  • [2] Cost analysis of migraine pharmacotherapy with selective 5HT1 receptor agonists in Ukraine
    Hrynkiv, Yaryna
    Zaliska, Olha
    Maksymovych, Nataliia
    Blavatska, Oksana
    PHARMACIA, 2021, 68 (01) : 235 - 241
  • [3] RATIONALE FOR THE USE OF 5-HT1-LIKE AGONISTS IN THE TREATMENT OF MIGRAINE
    FENIUK, W
    HUMPHREY, PPA
    PERREN, MJ
    CONNOR, HE
    WHALLEY, ET
    JOURNAL OF NEUROLOGY, 1991, 238 : S57 - S61
  • [4] 5-HT1F receptor agonists: A new treatment option for migraine attacks?
    Lars Neeb
    Jannis Meents
    Uwe Reuter
    Neurotherapeutics, 2010, 7 : 176 - 182
  • [5] 5-HT1F Receptor Agonists: A New Treatment Option for Migraine Attacks?
    Neeb, Lars
    Meents, Jannis
    Reuter, Uwe
    NEUROTHERAPEUTICS, 2010, 7 (02) : 176 - 182
  • [6] Clinical Pharmacokinetics of Almotriptan, a Serotonin 5-HT1B/1D Receptor Agonist for the Treatment of Migraine
    Janet D. McEnroe
    Joseph C. Fleishaker
    Clinical Pharmacokinetics, 2005, 44 : 237 - 246
  • [7] The effects of 5-HT1A, 5-HT1B and 5-HT1D receptor agonists on trigeminal nociceptive neurotransmission in anaesthetized rats
    Cumberbatch, MJ
    Hill, RG
    Hargreaves, RJ
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 362 (01) : 43 - 46
  • [8] Serotonin 5-HT1B/1D Receptor Agonists in MigraineComparative Pharmacology and Its Therapeutic Implications
    Peter J. Goadsby
    CNS Drugs, 1998, 10 : 271 - 286
  • [9] Cranial vascular effects of zolmitriptan, a centrally active 5-HT1B/1D receptor partial agonist for the acute treatment of migraine
    MacLennan, SJ
    Cambridge, D
    Whiting, MV
    Marston, C
    Martin, GR
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 361 (2-3) : 191 - 197
  • [10] THE DEVELOPMENT OF A HIGHLY SELECTIVE 5-HT(1) RECEPTOR AGONIST, SUMATRIPTAN, FOR THE TREATMENT OF MIGRAINE
    FENIUK, W
    HUMPHREY, PPA
    DRUG DEVELOPMENT RESEARCH, 1992, 26 (03) : 235 - 240
12345